ARK 每周股评 – 4/9/2022


We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

Twitter (TWTR)
+27%Shares of Twitter traded up over 27% on Monday after Elon Musk disclosed that he has taken a 9.2% stake in the company and that he shifted his stance from that of a passive investor (13G filing) to an activist investor (13D). Musk is a visionary entrepreneur and an active Twitter user whose appointment to its Board of Directors could benefit the company in unexpected ways. Twitter is a social media platform focused on short-form text.

注: 在埃隆-马斯克披露他已持有该公司9.2%的股份,并将其立场从被动投资者(13G文件)转变为积极投资者(13D)后,Twitter的股价周一上涨超过27%。马斯克是一位有远见的企业家,也是一位活跃的Twitter用户,他被任命为其董事会成员可能会以意想不到的方式使该公司受益。推特是一个专注于短文的社交媒体平台。
Castle Biosciences (CSTL)
-16%Shares of Castle Biosciences fell roughly 16% on Tuesday after the company announced plans to acquire AltheaDx, a private firm focused on pharmacogenomic (PGx) testing. Since its IPO, ARK’s thesis has hinged on Castle’s focus on and position in the underpenetrated dermatology market. We are concerned that the AltheaDx acquisition veers from Castle’s core competencies and could signal its transition into a diagnostic “roll-up” with an unclear expansion strategy.

注: 在Castle Biosciences宣布计划收购专注于药物基因组学(PGx)测试的私人公司AltheaDx之后,该公司的股票在周二下跌了大约16%。自上市以来,ARK的论点一直依赖于Castle对未被充分渗透的皮肤病市场的关注和定位。我们担心AltheaDx的收购偏离了Castle的核心竞争力,并可能预示着其过渡到一个扩张战略不明确的诊断 “滚动 “公司。
Velo3D (VLD)
-26%Shares of Velo3D dropped 26% on Wednesday following an SEC filing that disclosed potential supply-chain-related delays in the shipment of two of its printer models. Velo3D is a 3D printing company specializing in support-free powder bed fusion. SpaceX is its largest customer and strategic investor.

注: Velo3D的股价在周三下跌了26%,因为该公司向美国证券交易委员会提交了一份文件,披露了其两种打印机型号的出货量可能与供应链有关的延迟。Velo3D是一家3D打印公司,专门从事无支撑粉末床融合技术。SpaceX是其最大的客户和战略投资者。


上一篇 2022年4月8日 上午9:13
下一篇 2022年4月12日 上午9:07



您的电子邮箱地址不会被公开。 必填项已用*标注